Resistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics.

The metabolic end products of the large bowel microbiota contribute significantly to human health. After weaning to solid foods, some of the most important of these are the short chain fatty acids (SCFA) produced by the fermentation of undigested dietary components and endogenous secretions. The main SCFA are acetate, propionate and butyrate which have numerous documented effects promoting large bowel function. Of the major acids, butyrate seems especially important. It is a major metabolic fuel for colonocytes and promotes a normal phenotype in these cells, potentially lowering the risk of diseases such as colo-rectal cancer. Imbalances in the microbiota are thought to predispose to large bowel dysfunction and probiotics are being developed to correct this. However, most commercial products contain bacteria (lactobacilli and bifidobacteria) which are dominant species in milk-fed infants but have limited roles in adults. Prebiosis is defined usually by the specific stimulation of these bacteria. However, the end products of most probiotics do not include butyrate or propionate which raises questions about their effectiveness in promoting bowel health in adults. Resistant starch (RS) is a dietary fibre component and its fermentation generally favours butyrate production. Dietary RS intakes and faecal butyrate levels are high in populations at low risk of diet-related large bowel diseases. Conversely, RS intakes and faecal butyrate levels are very low in high risk groups. This raises the possibility that greater RS consumption could be of health benefit. RS is not regarded widely as a prebiotic but (according to the accepted definition) most forms show the requisite features in stimulating specific bacteria, giving raised total SCFA and butyrate levels and a consequent benefit to the host. Current efforts to improve public health through increasing RS consumption could be facilitated by greater recognition of its prebiotic role.

[1]  E. Lam,et al.  Butyrate-rich Colonic Microenvironment Is a Relevant Selection Factor for Metabolically Adapted Tumor Cells* , 2010, The Journal of Biological Chemistry.

[2]  C. Dejong,et al.  Butyrate Enemas Improve Intestinal Anastomotic Strength in a Rat Model , 2010, Diseases of the colon and rectum.

[3]  P. de Coppet,et al.  Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats. , 2010, Gastroenterology.

[4]  N. Petrovsky Immunomodulation with microbial vaccines to prevent type 1 diabetes mellitus , 2010, Nature Reviews Endocrinology.

[5]  S. Sørensen,et al.  Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults , 2010, PloS one.

[6]  B. Leggett,et al.  A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. , 2009, The American journal of clinical nutrition.

[7]  C. Duyckaerts,et al.  The second brain and Parkinson’s disease , 2009, The European journal of neuroscience.

[8]  D. Jonkers,et al.  The effects of butyrate enemas on visceral perception in healthy volunteers , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[9]  G. Brinkworth,et al.  Comparative effects of very low-carbohydrate, high-fat and high-carbohydrate, low-fat weight-loss diets on bowel habit and faecal short-chain fatty acids and bacterial populations. , 2009, The British journal of nutrition.

[10]  D. Topping,et al.  Comparative Effects of a High-Amylose Starch and a Fructooligosaccharide on Fecal Bifidobacteria Numbers and Short-Chain Fatty Acids in Pigs Fed Bifidobacterium animalis , 2009, Digestive Diseases and Sciences.

[11]  G. Young,et al.  Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. , 2009, The New England journal of medicine.

[12]  S. McColl,et al.  Proteomic analysis of butyrate effects and loss of butyrate sensitivity in HT29 colorectal cancer cells. , 2009, Journal of proteome research.

[13]  M. Kamm,et al.  Mechanisms of action of probiotics: Recent advances , 2009, Inflammatory bowel diseases.

[14]  M. Conlon,et al.  Phylotypes related to Ruminococcus bromii are abundant in the large bowel of humans and increase in response to a diet high in resistant starch. , 2008, FEMS microbiology ecology.

[15]  S. Kaufmann Elie Metchnikoff's and Paul Ehrlich's impact on infection biology. , 2008, Microbes and infection.

[16]  L. Cobiac,et al.  Butyrylated starch protects colonocyte DNA against dietary protein-induced damage in rats. , 2008, Carcinogenesis.

[17]  J. Mathers,et al.  Cell kinetics and gene expression changes in colorectal cancer patients given resistant starch: a randomised controlled trial , 2008, Gut.

[18]  L. Cobiac,et al.  Effects of high-amylose maize starch and butyrylated high-amylose maize starch on azoxymethane-induced intestinal cancer in rats , 2008, Carcinogenesis.

[19]  G. Moro,et al.  Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. , 2008, The Journal of nutrition.

[20]  W. Walker Mechanisms of action of probiotics. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  L. Cobiac,et al.  Excretion of starch and esterified short-chain fatty acids by ileostomy subjects after the ingestion of acylated starches. , 2007, The American journal of clinical nutrition.

[22]  R. Aminov,et al.  Importance of microbial colonization of the gut in early life to the development of immunity. , 2007, Mutation research.

[23]  J. Saavedra Use of probiotics in pediatrics: rationale, mechanisms of action, and practical aspects. , 2007, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[24]  A. Schatzkin,et al.  Dietary fiber and whole-grain consumption in relation to colorectal cancer in the NIH-AARP Diet and Health Study. , 2007, The American journal of clinical nutrition.

[25]  P. Mannon,et al.  The fundamental basis of inflammatory bowel disease. , 2007, The Journal of clinical investigation.

[26]  D. Topping,et al.  Dose-dependent reduction of dietary protein-induced colonocyte DNA damage by resistant starch in rats correlates more highly with caecal butyrate than with other short chain fatty acids , 2007, Cancer biology & therapy.

[27]  H. Flint,et al.  Reduced Dietary Intake of Carbohydrates by Obese Subjects Results in Decreased Concentrations of Butyrate and Butyrate-Producing Bacteria in Feces , 2006, Applied and Environmental Microbiology.

[28]  P. Turnbaugh,et al.  Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.

[29]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[30]  O. Gabrielli,et al.  Prebiotics in human milk: a review. , 2006, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[31]  P. Jones,et al.  Probiotics and their potential health claims. , 2006, Nutrition reviews.

[32]  R. Black,et al.  Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. , 2006, The Lancet. Infectious diseases.

[33]  R. D. de Souza,et al.  Colonic Health: Fermentation and Short Chain Fatty Acids , 2006, Journal of clinical gastroenterology.

[34]  D. Topping,et al.  Resistant starch prevents colonic DNA damage induced by high dietary cooked red meat or casein in rats , 2006, Cancer biology & therapy.

[35]  I. Brown,et al.  Comparative Effects of Acetylated and Unmodified High-amylose Maize Starch in Rats , 2005 .

[36]  D. Sklan,et al.  Mucin dynamics and microbial populations in chicken small intestine are changed by dietary probiotic and antibiotic growth promoter supplementation. , 2005, The Journal of nutrition.

[37]  C. Nord,et al.  Probiotics and gastrointestinal diseases , 2005, Journal of internal medicine.

[38]  M. Roberfroid,et al.  Dietary modulation of the human colonic microbiota: updating the concept of prebiotics , 2004, Nutrition Research Reviews.

[39]  M. Gorospe,et al.  Acquisition of Resistance to Butyrate Enhances Survival after Stress and Induces Malignancy of Human Colon Carcinoma Cells , 2004, Cancer Research.

[40]  C. Mascie-Taylor,et al.  The Burden of Chronic Disease , 2003, Science.

[41]  J. Davie Inhibition of histone deacetylase activity by butyrate. , 2003, The Journal of nutrition.

[42]  Paolo Vineis,et al.  Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study , 2003, The Lancet.

[43]  P. Brigidi,et al.  PCR detection of Bifidobacterium strains and Streptococcus thermophilus in feces of human subjects after oral bacteriotherapy and yogurt consumption. , 2003, International journal of food microbiology.

[44]  S. Matsubara,et al.  Evaluation of Bifidobacterium breve strain Yakult-fermented soymilk as a probiotic food. , 2003, International journal of food microbiology.

[45]  J. Mathers,et al.  Anti-cancer effects of butyrate: use of micro-array technology to investigate mechanisms , 2003, Proceedings of the Nutrition Society.

[46]  D. Topping,et al.  Resistant starch as a prebiotic and synbiotic: state of the art , 2003, Proceedings of the Nutrition Society.

[47]  C. Edwards,et al.  Intestinal flora during the first months of life: new perspectives , 2002, British Journal of Nutrition.

[48]  B. Kettlitz,et al.  Resistant starch and “the butyrate revolution” , 2002 .

[49]  W. Bryden,et al.  Dietary n-3 and n-6 fatty acids alter avian metabolism: metabolism and abdominal fat deposition. , 2002, The British journal of nutrition.

[50]  I. Segal Physiological small bowel malabsorption of carbohydrates protects against large bowel diseases in Africans , 2002, Journal of gastroenterology and hepatology.

[51]  B. Stahl,et al.  Dosage-Related Bifidogenic Effects of Galacto- and Fructooligosaccharides in Formula-Fed Term Infants , 2002, Journal of pediatric gastroenterology and nutrition.

[52]  P. Clifton,et al.  Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. , 2001, Physiological reviews.

[53]  Andrew J. Wilson,et al.  Resistance to butyrate-induced cell differentiation and apoptosis during spontaneous Caco-2 cell differentiation. , 2001, Gastroenterology.

[54]  K. Ebihara,et al.  Hydroxypropyl-distarch phosphate from Tapioca starch reduces zinc and iron absorption, but not calcium and magnesium absorption, in rats. , 2001, The Journal of nutrition.

[55]  Y. Seto,et al.  Intestinal transit of an orally administered streptomycin–rifampicin‐resistant variant of Bifidobacterium longum SBT2928: its long‐term survival and effect on the intestinal microflora and metabolism , 2001, Journal of applied microbiology.

[56]  J. Doré,et al.  Quantification of Bacterial Groups within Human Fecal Flora by Oligonucleotide Probe Hybridization , 2000, Applied and Environmental Microbiology.

[57]  R. Ahmed,et al.  Fermentation of dietary starch in humans , 2000, American Journal of Gastroenterology.

[58]  D. Topping,et al.  Starches, resistant starches, the gut microflora and human health. , 2000, Current issues in intestinal microbiology.

[59]  G. Young,et al.  Amylase-resistant starch plus oral rehydration solution for cholera. , 2000, The New England journal of medicine.

[60]  W. M. Vos,et al.  Probiotics: Towards demonstrating efficacy , 1999 .

[61]  C. Cherbut,et al.  In vitro prebiotic effects of Acacia gums onto the human intestinal microbiota depends on both botanical origin and environmental pH. , 1998, Anaerobe.

[62]  J. Galmiche,et al.  Short-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[63]  M. Warhurst,et al.  Fecal numbers of bifidobacteria are higher in pigs fed Bifidobacterium longum with a high amylose cornstarch than with a low amylose cornstarch. , 1997, The Journal of nutrition.

[64]  A. Cats,et al.  Regional differences of physiological functions and cancer susceptibility in the human large intestine. , 1996, International journal of oncology.

[65]  M. Hill,et al.  Bacterial fermentation of complex carbohydrate in the human colon. , 1995, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[66]  P. Becker,et al.  Fecal short chain fatty acids in South African Urban Africans and whites , 1995, Diseases of the colon and rectum.

[67]  I. Finnie,et al.  Colonic mucin synthesis is increased by sodium butyrate. , 1995, Gut.

[68]  S. Bingham,et al.  Starch intake and colorectal cancer risk: an international comparison. , 1994, British Journal of Cancer.

[69]  F. Nagengast,et al.  Effect of resistant starch on colonic fermentation, bile acid metabolism, and mucosal proliferation , 1994, Digestive Diseases and Sciences.

[70]  G. Macfarlane,et al.  The control and consequences of bacterial fermentation in the human colon. , 1991, The Journal of applied bacteriology.

[71]  E. N. Bergman Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. , 1990, Physiological reviews.

[72]  H. Englyst,et al.  Fermentation in the human large intestine and the available substrates. , 1987, The American journal of clinical nutrition.

[73]  D. Topping,et al.  Effects of food restriction and starvation-refeeding on volatile fatty acid concentrations in the rat. , 1986, The Journal of nutrition.

[74]  E. Newsholme,et al.  Fuel utilization in colonocytes of the rat. , 1985, The Biochemical journal.

[75]  A. Walker,et al.  Bowel behaviour in young black and white children. , 1985, Archives of disease in childhood.

[76]  A. Walker,et al.  Faecal pH value and its modification by dietary means in South African black and white schoolchildren. , 1979, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[77]  D. Burkitt,et al.  Relationship as a clue to causation. , 1970, Lancet.

[78]  M. Morell,et al.  Resistant starch and human health. , 2010 .

[79]  J. Delcour,et al.  Wheat bran derived arabinoxylanoligosaccharides: a novel prebiotic concept? , 2010 .

[80]  F. Shanahan,et al.  The survival and colonic adhesion of Bifidobacterium infantis in patients with ulcerative colitis , 2002 .

[81]  W. M. Vos,et al.  Polymerase chain reaction and denaturing gradient gel electrophoresis monitoring of fecal bifidobacterium populations in a prebiotic and probiotic feeding trial. , 2001, Systematic and applied microbiology.

[82]  H. Harmsen,et al.  Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. , 2000, Journal of pediatric gastroenterology and nutrition.

[83]  C. Paraskeva,et al.  A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate. , 2000, Carcinogenesis.

[84]  G. Macfarlane,et al.  The Human Colonic Microbiota , 1999 .

[85]  E. Ceriati,et al.  The effect of mucin on bacterial translocation in I-407 fetal and Caco-2 adult enterocyte cultured cell lines , 1999, Pediatric Surgery International.

[86]  P. Baghurst,et al.  Dietary fibre, non-starch polysaccharides and resistant starch : A review , 1996 .

[87]  W. Roediger The place of short chain fatty acids in colonocyte metabolism in health and in ulcerative colitis: the impaired colonocyte barrier. , 1995 .

[88]  D. Topping,et al.  Effects of starvation-refeeding on volatile fatty acid distribution in the large bowel of the rat , 1990 .

[89]  Roediger We Short chain fatty acids as metabolic regulators of ion absorption in the colon. , 1989 .